AKT1 and Parkinson disease: The Wnt-PI3K/AKT pathway was evaluated in this study as it has been reported to be impacted by mutations in Parkinson’s disease (PD) (Bravo-San Pedro et al., 2013; Rabanal-Ruiz et al., 2017; Madureira et al., 2020).